These include some heartburn medicines, including esomeprazole (Nexium), famotidine (Pepcid AC), lansoprazole (Prevacid), omeprazole (Prilosec OTC), pantoprazole (Protonix), rabeprazole (Aciphex), as well as some diabetes, gout, and chemotherapy drugs
U54HD061221), which is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and NIH K08DK106453
Presented for research literature review only Mack RB (1996)
A randomized, placebo-controlled, single and multiple dose study published in Annals of the New York Academy of Sciences evaluated the safety of TB4, a molecule that is identical to TB-500 in structure and function
Hydrogenated Lecithin Helps support the skin barrier